Page last updated: 2024-12-11

1,3,5,6-tetrahydroxyxanthone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,5,6-Tetrahydroxyxanthone is a natural compound belonging to the xanthone family, commonly found in plants, especially in the genus *Garcinia*.

**Properties and Structure:**

* **Chemical Formula:** C13H8O6
* **Molecular Weight:** 260.19 g/mol
* **Appearance:** Yellowish solid
* **Structure:** It consists of a xanthone core with four hydroxyl groups (-OH) attached at positions 1, 3, 5, and 6.

**Why it is Important for Research:**

1,3,5,6-Tetrahydroxyxanthone has attracted significant research interest due to its diverse biological activities, which include:

* **Antioxidant Activity:** It exhibits potent antioxidant properties, effectively scavenging free radicals and protecting cells from oxidative damage. This has implications for preventing diseases associated with oxidative stress, such as cancer and neurodegenerative disorders.
* **Anti-Inflammatory Activity:** Studies have shown its ability to suppress inflammation by inhibiting the production of pro-inflammatory mediators like TNF-α and IL-6. This potential makes it a promising candidate for treating inflammatory conditions like arthritis and asthma.
* **Anti-Cancer Activity:** Research suggests that 1,3,5,6-tetrahydroxyxanthone possesses cytotoxic effects against various cancer cell lines. Its mechanisms of action include inducing apoptosis (programmed cell death) and inhibiting cell proliferation.
* **Antimicrobial Activity:** It has been shown to exhibit activity against a range of bacteria, including *Staphylococcus aureus* and *Escherichia coli*. This potential makes it a promising candidate for developing new antimicrobial agents.
* **Anti-Viral Activity:** Preliminary studies indicate potential antiviral activity against certain viruses, although further research is needed to confirm this.

**Current Research Focus:**

* **Drug Development:** Researchers are actively exploring the therapeutic potential of 1,3,5,6-tetrahydroxyxanthone in developing novel drugs for various diseases.
* **Pharmacokinetic Studies:** Research is ongoing to understand the absorption, distribution, metabolism, and excretion (ADME) of this compound, crucial for optimizing its efficacy and safety for therapeutic use.
* **Mechanism of Action:** Scientists are investigating the molecular mechanisms underlying the biological activities of 1,3,5,6-tetrahydroxyxanthone, which will aid in developing more targeted and effective therapies.

**Overall, 1,3,5,6-tetrahydroxyxanthone is a natural compound with diverse biological activities, making it a promising candidate for developing new drugs and therapies for various diseases. However, further research is needed to fully understand its potential and optimize its use.**

1,3,5,6-tetrahydroxyxanthone: from roots of Cudrania cochinchinensis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5479774
CHEMBL ID448040
SCHEMBL ID2313484
MeSH IDM0521144

Synonyms (11)

Synonym
1,3,5,6-tetrahydroxyxanthen-9-one
1,3,5,6-tetrahydroxyxanthone
1,3,5,6-tetrahydroxyxantone
CHEMBL448040 ,
bdbm50292547
5084-31-1
SCHEMBL2313484
1,3,5,6-tetrahydroxy-9h-xanthen-9-one
DTXSID80420484
AKOS030562600
FS-7794
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Angiotensin-converting enzyme Homo sapiens (human)IC50 (µMol)69.20000.00010.533610.0000AID335366
Angiotensin-converting enzyme Homo sapiens (human)Ki34.20000.00000.82557.5000AID335370
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (56)

Processvia Protein(s)Taxonomy
response to hypoxiaAngiotensin-converting enzyme Homo sapiens (human)
kidney developmentAngiotensin-converting enzyme Homo sapiens (human)
blood vessel remodelingAngiotensin-converting enzyme Homo sapiens (human)
angiotensin maturationAngiotensin-converting enzyme Homo sapiens (human)
regulation of renal output by angiotensinAngiotensin-converting enzyme Homo sapiens (human)
neutrophil mediated immunityAngiotensin-converting enzyme Homo sapiens (human)
antigen processing and presentation of peptide antigen via MHC class IAngiotensin-converting enzyme Homo sapiens (human)
regulation of systemic arterial blood pressure by renin-angiotensinAngiotensin-converting enzyme Homo sapiens (human)
proteolysisAngiotensin-converting enzyme Homo sapiens (human)
spermatogenesisAngiotensin-converting enzyme Homo sapiens (human)
female pregnancyAngiotensin-converting enzyme Homo sapiens (human)
regulation of blood pressureAngiotensin-converting enzyme Homo sapiens (human)
male gonad developmentAngiotensin-converting enzyme Homo sapiens (human)
response to xenobiotic stimulusAngiotensin-converting enzyme Homo sapiens (human)
embryo development ending in birth or egg hatchingAngiotensin-converting enzyme Homo sapiens (human)
post-transcriptional regulation of gene expressionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of gene expressionAngiotensin-converting enzyme Homo sapiens (human)
substance P catabolic processAngiotensin-converting enzyme Homo sapiens (human)
bradykinin catabolic processAngiotensin-converting enzyme Homo sapiens (human)
regulation of smooth muscle cell migrationAngiotensin-converting enzyme Homo sapiens (human)
regulation of vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
animal organ regenerationAngiotensin-converting enzyme Homo sapiens (human)
response to nutrient levelsAngiotensin-converting enzyme Homo sapiens (human)
response to lipopolysaccharideAngiotensin-converting enzyme Homo sapiens (human)
mononuclear cell proliferationAngiotensin-converting enzyme Homo sapiens (human)
response to laminar fluid shear stressAngiotensin-converting enzyme Homo sapiens (human)
angiotensin-activated signaling pathwayAngiotensin-converting enzyme Homo sapiens (human)
vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
hormone metabolic processAngiotensin-converting enzyme Homo sapiens (human)
hormone catabolic processAngiotensin-converting enzyme Homo sapiens (human)
eating behaviorAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of apoptotic processAngiotensin-converting enzyme Homo sapiens (human)
peptide catabolic processAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of vasoconstrictionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of glucose importAngiotensin-converting enzyme Homo sapiens (human)
regulation of synaptic plasticityAngiotensin-converting enzyme Homo sapiens (human)
lung alveolus developmentAngiotensin-converting enzyme Homo sapiens (human)
amyloid-beta metabolic processAngiotensin-converting enzyme Homo sapiens (human)
arachidonic acid secretionAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of neurogenesisAngiotensin-converting enzyme Homo sapiens (human)
heart contractionAngiotensin-converting enzyme Homo sapiens (human)
regulation of angiotensin metabolic processAngiotensin-converting enzyme Homo sapiens (human)
hematopoietic stem cell differentiationAngiotensin-converting enzyme Homo sapiens (human)
angiogenesis involved in coronary vascular morphogenesisAngiotensin-converting enzyme Homo sapiens (human)
cellular response to glucose stimulusAngiotensin-converting enzyme Homo sapiens (human)
response to dexamethasoneAngiotensin-converting enzyme Homo sapiens (human)
cell proliferation in bone marrowAngiotensin-converting enzyme Homo sapiens (human)
regulation of heart rate by cardiac conductionAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of calcium ion importAngiotensin-converting enzyme Homo sapiens (human)
response to thyroid hormoneAngiotensin-converting enzyme Homo sapiens (human)
blood vessel diameter maintenanceAngiotensin-converting enzyme Homo sapiens (human)
regulation of hematopoietic stem cell proliferationAngiotensin-converting enzyme Homo sapiens (human)
negative regulation of gap junction assemblyAngiotensin-converting enzyme Homo sapiens (human)
cellular response to aldosteroneAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of peptidyl-cysteine S-nitrosylationAngiotensin-converting enzyme Homo sapiens (human)
positive regulation of systemic arterial blood pressureAngiotensin-converting enzyme Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
endopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
carboxypeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
metalloendopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
calmodulin bindingAngiotensin-converting enzyme Homo sapiens (human)
peptidase activityAngiotensin-converting enzyme Homo sapiens (human)
metallopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
exopeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
tripeptidyl-peptidase activityAngiotensin-converting enzyme Homo sapiens (human)
peptidyl-dipeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
zinc ion bindingAngiotensin-converting enzyme Homo sapiens (human)
chloride ion bindingAngiotensin-converting enzyme Homo sapiens (human)
mitogen-activated protein kinase kinase bindingAngiotensin-converting enzyme Homo sapiens (human)
bradykinin receptor bindingAngiotensin-converting enzyme Homo sapiens (human)
mitogen-activated protein kinase bindingAngiotensin-converting enzyme Homo sapiens (human)
metallodipeptidase activityAngiotensin-converting enzyme Homo sapiens (human)
heterocyclic compound bindingAngiotensin-converting enzyme Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
extracellular spaceAngiotensin-converting enzyme Homo sapiens (human)
extracellular regionAngiotensin-converting enzyme Homo sapiens (human)
extracellular spaceAngiotensin-converting enzyme Homo sapiens (human)
lysosomeAngiotensin-converting enzyme Homo sapiens (human)
endosomeAngiotensin-converting enzyme Homo sapiens (human)
plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
external side of plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
basal plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
brush border membraneAngiotensin-converting enzyme Homo sapiens (human)
extracellular exosomeAngiotensin-converting enzyme Homo sapiens (human)
sperm midpieceAngiotensin-converting enzyme Homo sapiens (human)
plasma membraneAngiotensin-converting enzyme Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1525036Cytotoxicity in human HT-29 cells incubated for 72 hrs by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Tetrandraxanthones A-I, Prenylated and Geranylated Xanthones from the Stem Bark of Garcinia tetrandra.
AID1525032Cytotoxicity in human KB cells incubated for 72 hrs by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Tetrandraxanthones A-I, Prenylated and Geranylated Xanthones from the Stem Bark of Garcinia tetrandra.
AID335368Inhibition of ACE at 200 uM1992Journal of natural products, May, Volume: 55, Issue:5
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.
AID1607896Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 25.0 mg/ml after 24 hrs by Griess reagent based assay relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
AID335367Inhibition of ACE at 100 uM1992Journal of natural products, May, Volume: 55, Issue:5
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.
AID1520339Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166All that glitters is not gold: Panning cytotoxic natural products and derivatives with a fused tricyclic backbone by the estimation of their leadlikeness for cancer treatment.
AID333524Cytotoxicity against human MCF7 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID335369Inhibition of ACE at 400 uM1992Journal of natural products, May, Volume: 55, Issue:5
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.
AID1525035Cytotoxicity in human HepG2 cells incubated for 72 hrs by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Tetrandraxanthones A-I, Prenylated and Geranylated Xanthones from the Stem Bark of Garcinia tetrandra.
AID335370Inhibition of ACE by Lineweaver-Burke plot1992Journal of natural products, May, Volume: 55, Issue:5
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.
AID333523Cytotoxicity against human A549 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID1525033Cytotoxicity in human HeLaS3 cells incubated for 72 hrs by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Tetrandraxanthones A-I, Prenylated and Geranylated Xanthones from the Stem Bark of Garcinia tetrandra.
AID335366Inhibition of ACE1992Journal of natural products, May, Volume: 55, Issue:5
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.
AID1525034Cytotoxicity in human MCF7 cells incubated for 72 hrs by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Tetrandraxanthones A-I, Prenylated and Geranylated Xanthones from the Stem Bark of Garcinia tetrandra.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]